CP96

tachykinin precursor 1 ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 17071590 An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. 2006 Nov 2
2 14743438 A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons. 2004 Feb 15 1
3 14622931 Tritiation of nonpeptide substance P antagonist CP-96,345 and its azido analogue. Synthetic and characterization details. 2003 Nov-Dec 1
4 12098517 A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes. 2002 Jul 2
5 12383866 Substance P (NK(1)) receptor expression by human colonic epithelial cell line Caco-2. 2002 Oct 2
6 11274418 Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. 2001 Mar 27 3
7 10030226 Effect of intravenous substance P on laryngeal adductor activity in young dogs. 1999 Feb 2
8 8622630 Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist. 1996 May 1
9 8672532 Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C. 1996 Jun 13 1
10 8738221 Medial amygdaloid suppression of predatory attack behavior in the cat: I Role of a substance P pathway from the medial amygdala to the medial hypothalamus. 1996 Apr 15 2
11 8944719 Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. 1996 Nov 1
12 8997258 Protective effect of substance P on permeability of airway epithelial cells in culture. 1996 Dec 1
13 7537470 Substance P increases microvascular permeability via nitric oxide-mediated convective pathways. 1995 Apr 2
14 7511664 Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. 1994 Apr 15 1
15 7512452 Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. 1994 May 1
16 7512575 Interleukin-6 secretion from human astrocytoma cells induced by substance P. 1994 Apr 1
17 7525925 NK1 receptors mediated release of 6-keto-PGF1 alpha from the ex vivo perfused canine ileum. 1994 Oct 1
18 8556479 Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. 1994 Jul 1
19 7679096 Molecular basis for the species selectivity of the substance P antagonist CP-96,345. 1993 Feb 5 5
20 7683033 Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. 1993 May 1 1
21 7692490 Discovery of CP-96,345 and its characterization in disease models involving substance P. 1993 Jul 2 1
22 7692533 Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580. 1993 Jul 2 1
23 8394992 Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system. 1993 Aug 3
24 1279753 Neurokinin 1 receptors mediate substance P-induced changes in ion transport in guinea-pig ileum. 1992 Jun 11 1
25 1319017 NK-1, but not NK-2, tachykinin receptors mediate plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw: demonstrated with the NK-1 antagonist CP-96,345 and the NK-2 antagonist Men 10207. 1992 May 25 1
26 1378274 A selective and potent antagonist of substance P receptors on pancreatic acinar cells. 1992 Jun 2
27 1378901 The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. 1992 Jul 10 2
28 1385177 The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels. 1992 Sep 4 1
29 1722327 Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. 1991 Dec 15 1